NASDAQ:PRPH ProPhase Labs (PRPH) News Today $4.39 +0.03 (+0.69%) (As of 10/4/2023 ET) Add Compare Share Share Today's Range$4.33▼$4.4850-Day Range$4.23▼$7.4852-Week Range$4.05▼$12.69Volume28,634 shsAverage Volume55,038 shsMarket Capitalization$73.93 millionP/E RatioN/ADividend YieldN/APrice Target$14.00 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProPhase Labs (NASDAQ:PRPH) Downgraded to Sell at StockNews.comamericanbankingnews.com - October 4 at 4:29 AMProPhase Labs (NASDAQ:PRPH) Shares Pass Below 200 Day Moving Average of $7.10americanbankingnews.com - September 29 at 3:00 AMAre ProPhase Labs, Inc. (NASDAQ:PRPH) Investors Paying Above The Intrinsic Value?finance.yahoo.com - August 31 at 9:06 AMProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2023 Earnings Call Transcriptinsidermonkey.com - August 14 at 1:01 PMProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.finance.yahoo.com - August 10 at 1:17 PMProPhase Labs Announces Financial Results for the Three Months Ended June 30, 2023finance.yahoo.com - August 10 at 8:16 AMProPhase Labs Teams up with Certis Oncology to Accelerate Development of Novel Linebacker Compoundfinance.yahoo.com - August 3 at 10:48 AMProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Timefinance.yahoo.com - August 2 at 8:44 AMNavidea Biopharmaceuticals Rejects ProPhase Labs Offer To Acquire Certain Assets of Navideafinance.yahoo.com - June 29 at 12:47 PMChapin Davis Inc. Invests $229,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - June 23 at 7:18 AMProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buymsn.com - June 11 at 1:52 AMHRT Financial LP Invests $204,000 in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - June 9 at 4:36 AMProPhase Labs to Present at the Diamond Equity Research Emerging Growth Invitational on Tuesday, June 13, 2023finance.yahoo.com - June 7 at 9:21 AMHC Wainwright & Co. Reiterates ProPhase Labs (PRPH) Buy Recommendationmsn.com - June 2 at 3:24 PMH.C. Wainwright Remains a Buy on Prophase Labs (PRPH)markets.businessinsider.com - June 2 at 10:24 AMProPhase Labs’ Cancer Therapeutic, Linebacker-1, pre-clinical studies with Dana Farber/Harvard Cancer Institute demonstrate impressive utility and move into next phase of testingfinance.yahoo.com - June 1 at 3:25 PMO Shaughnessy Asset Management LLC Boosts Position in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - May 30 at 6:24 AMStockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH)marketbeat.com - May 18 at 4:35 AMHere's what Wall Street expects from ProPhase Labs's earnings reportmarkets.businessinsider.com - May 13 at 12:04 AMHC Wainwright & Co. Maintains ProPhase Labs (PRPH) Buy Recommendationmsn.com - May 12 at 2:01 PMAnalyst Expectations for ProPhase Labs's Futuremarkets.businessinsider.com - May 12 at 2:01 PMRecap: ProPhase Labs Q1 Earningsmsn.com - May 11 at 10:59 PMProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2023finance.yahoo.com - May 11 at 12:59 PMProPhase Labs, Inc. (PRPH) Beats Q1 Earnings and Revenue Estimatesfinance.yahoo.com - May 11 at 12:59 PMProPhase Labs Q1 2023 Earnings Previewmsn.com - May 10 at 9:24 PMProPhase Labs hires Dr. Matthew Halpert to Drive Company's Key Therapeutic and Diagnostic Oncology Programsmarketwatch.com - May 8 at 11:06 PMProPhase Labs hires Dr. Matthew Halpert to Drive Company’s Key Therapeutic and Diagnostic Oncology Programsfinance.yahoo.com - May 8 at 1:05 PMProPhase Labs (PRPH) Scheduled to Post Earnings on Thursdaymarketbeat.com - May 5 at 9:46 AMProPhase Labs to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 11, 2023 at 11:00 a.m. Eastern Timefinance.yahoo.com - May 4 at 10:38 AMProPhase Labs, Inc. to Post Q1 2023 Earnings of ($0.11) Per Share, Diamond Equity Forecasts (NASDAQ:PRPH)marketbeat.com - May 4 at 7:04 AMProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?finance.yahoo.com - May 3 at 9:46 AMProPhase Labs’ Linebacker-1 Cancer Therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including lung and gastric cancersfinance.yahoo.com - May 3 at 9:46 AMDiamond Equity Research Initiates Coverage on ProPhase Labs Inc. (NASDAQ: PRPH)finance.yahoo.com - May 1 at 8:59 AMBank of Montreal Can Acquires New Position in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - May 1 at 4:48 AMProPhase Labs CEO Ted Karkus Named One of Inc Magazine's 10 Most Innovative Healthcare Leaders to Watch in 2023marketwatch.com - April 29 at 12:58 AMProPhase Labs, Inc. (NASDAQ:PRPH) Sees Significant Growth in Short Interestmarketbeat.com - April 28 at 4:56 PMProPhase Labs CEO Ted Karkus Named One of Inc Magazine’s 10 Most Innovative Healthcare Leaders to Watch in 2023finance.yahoo.com - April 28 at 9:56 AM7 Small-Cap Biotech Stocks with Massive Potentialmarkets.businessinsider.com - April 27 at 8:01 PMCOMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committeefinance.yahoo.com - April 27 at 9:45 AMCould The Market Be Wrong About ProPhase Labs, Inc. (NASDAQ:PRPH) Given Its Attractive Financial Prospects?finance.yahoo.com - April 27 at 9:45 AMProPhase Labs Announces Launch of Redesigned Corporate Websitefinance.yahoo.com - April 25 at 2:49 PMNavellier & Associates Inc. Raises Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH)marketbeat.com - April 21 at 9:29 AMProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023finance.yahoo.com - April 18 at 8:08 AMHC Wainwright Weighs in on ProPhase Labs, Inc.'s Q1 2023 Earnings (NASDAQ:PRPH)marketbeat.com - April 3 at 1:24 AMProPhase Labs' (NASDAQ:PRPH) investors will be pleased with their enviable 352% return over the last three yearsfinance.yahoo.com - March 31 at 10:29 AMProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2022 Earnings Call Transcriptfinance.yahoo.com - March 30 at 8:48 AMProPhase Labs is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - March 29 at 3:29 PMH.C. Wainwright Keeps Their Buy Rating on Prophase Labs (PRPH)markets.businessinsider.com - March 29 at 3:29 PMProPhase Labs Announces Record Financial Results for the year ended December 31, 2022finance.yahoo.com - March 28 at 1:12 PMProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimatesfinance.yahoo.com - March 28 at 1:12 PM Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address PRPH Media Mentions By Week PRPH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRPH News Sentiment▼0.560.47▲Average Medical News Sentiment PRPH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRPH Articles This Week▼21▲PRPH Articles Average Week Get ProPhase Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PYXS News Today KRON News Today DRRX News Today VERU News Today CRVS News Today SCYX News Today VHAQ News Today ELYM News Today HCWB News Today IXHL News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:PRPH) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProPhase Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.